Healthcare Stocks 2022, Part 1: The Future of Medtech

Throwing treatments at the wall to see what sticks has been the standard operating procedure since our great-great-grandparents’ time. Finally, after centuries of wandering around in the dark, doctors have essentially been gifted a road map and a flashlight... Throwing treatments at the wall to see what sticks has been the standard operating procedure since our great-great-grandparents’ time. Finally, after centuries of wandering around in the dark, doctors have essentially been gifted a road map and a flashlight... [Energy and Capital logo] Healthcare Stocks 2022, Part 1: The Future of Medtech [Luke Sweeney Photo] By [Luke Sweeney]( Written Sep 20, 2021 As with any new tech that threatens the status quo, there’s a ton of money riding on this young industry crashing and burning. As a humble member of the working class, I was understandably thrilled to see that the personalized medicine market is planning to do exactly the opposite. Even the most pessimistic forecasts are expecting the market to soar upward of $800 billion by the end of the decade. [Image 1 - Future Revenue] Like any American, paying for health care is a significant portion of my own expenses. Any solution to this broken system will hear no complaints from me. Throwing treatments at the wall to see what sticks has been the standard operating procedure since our great-great-grandparents’ time. Finally, after centuries of wandering around in the dark, doctors have essentially been gifted a road map and a flashlight. Let me show you exactly where this market is headed… Apple’s Newest Tech Could Hand You 20x Your Money Apple is coming out with a brand-new technology that’s going to be 1,000x bigger than the iPhone, iPad, and iPod combined. Think of it as every electronic device you’ve ever owned rolled into one brand-new device. But the best part? You don’t have to buy a single share of Apple to reap the benefits. [Click here to get all the details.]( Health Care Made for You and You Only In case you haven't come across it yet, personalized medicine is a rapidly maturing industry that uses DNA analysis to diagnose and treat just about every illness you can imagine. [Image 2 - Genetic Medicine] Similarly, data from telemedicine combines with artificial intelligence (AI) to create a complete snapshot of each patient’s unique healthcare needs, taking all the potentially lethal guesswork out of medical care. It works at every level: Genetic analysis can help determine what is making you sick, which specific treatment will work best, and how to keep you away from the doctor’s office longer. Anyone familiar with medical diagnostics knows that’s a breeze compared with the current process. Nowadays, finding out what's wrong with you can take days of poking and prodding — all of which will send your medical bill through the roof. In 2019, genetic medicine injected $265 billion directly into the economy through testing, genome sequencing, and research. Massive companies like Google and IBM are starting to follow the money, each with their own unique spin on genetic analysis. In a world where unique individuals are bombarded with generic catchall treatments, patients are finally starting to ask the important questions. For example... Trump’s “Final Act” Gifts America a $1.9 Trillion Opportunity On January 5, 2021, just days before his tenure was over... President Trump signed Executive Order 13972... Placing a revolutionary American fuel at the heart of ensuring... “[The] economic prosperity of the United States.” And now this incredible “metal fuel” could be on the verge of triggering a $1.9 trillion energy "reset"... That could hand patriots a once-in-a-lifetime 46,018% return opportunity. This has nothing to do with solar or wind, and it’s not some sort of new coal, oil, or gas either. [Click here to discover this incredible technology Trump saw as essential to America's success.]( “Why Should I Pay for Someone Else’s Health Care?” I hear this concern all too frequently when the topic of universal health care makes its rounds on mainstream media. And at the risk of sounding like Ebenezer Scrooge, I’ll wholeheartedly agree it’s a question that needs asking. Why should I have to fork over my own money for a service that doesn't benefit me personally? In the case of personalized medicine, the same concept holds true. Why would I pay for treatment that was designed for a totally different person? Or, in many cases, a treatment designed to work with millions of different people? These are the big questions that are driving the future of medical care. Estimates show that nearly 60% of everyone on Earth will be subjected to a genetic illness at some point in their lives. That means billions of people are just one step away from becoming one of the biggest markets on the planet. [Image 3 - Genetic Disease Prevalence] As of 2019, the U.S. spends approximately $11,000 per citizen on health care each year. About 29% of that cost is shouldered by the federal government, aka the taxpayers. The public has been a little spooked by genetic engineering in the past, but new polls show that the tides are quickly turning. One study showed that more than 85% of people were confident in personalized medicine’s ability to improve health care. Now that public confidence is finally catching up to science, those market predictions could already be obsolete. The biotech industry is churning out new treatments for things like cancer, HIV, and diabetes. All things considered, I wouldn't be the least bit surprised to see personalized health care mount a full-scale takeover of the medical industry as early as next year. We are witnessing the dawn of a totally new era of medical technology. Enjoy your next in-person visit to the doctor — it could very well be one of your last! To your wealth, Luke Sweeney Contributor, Energy and Capital --------------------------------------------------------------- The $5 Stock Behind This $15 Trillion Breakthrough Over the last three years, a small, secretive company has been quietly filing 140 patents for a revolutionary technology. Forbes describes this technology as “transformative,” and big names are lining up to invest. When Jeff Bezos experienced this tech firsthand, he didn’t hesitate. He immediately invested a cool $116 million. But you don’t need to invest $116 million to reap the benefits of this once-in-a-lifetime opportunity. A modest $500 investment could be enough to bag you extraordinary gains of as much as $1.5 million in the coming years. It’s not as unbelievable as you think. If you had invested in a small Seattle tech company called Microsoft in 1986, you could have turned $500 into $1.1 million dollars. That’s a 237,400% return. Or what if you picked up 500 shares of McDonald’s back in 1965? You would have bagged gains of 68,270%. But the company I want to tell you about is doing something that is much more revolutionary than fast food or computers. In fact, I’ve just finished putting together a report that has all of the details on this unknown company, its revolutionary technology, and the 140 patents that could make it a household name. And I’m finally ready to share this free report with you. [Click here now to gain access to your report on the $5 stock behind this $15 trillion breakthrough…]( Browse Our Archives [The 63-Year-Old Secret Clue Hidden Behind Peach Bottom 1]( [Has Biden Gone Senile?]( [Why Taxing the Rich Will Lead to Unintended Consequences That Will Persecute the Poor and Middle Class]( [Teaching Self-Driving Cars to Read With Micro-Rainbows]( [Options Action Friday — Sell DELL]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street, Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.